Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Stefano Morotti (auth)
Otros Autores: Eleonora Grandi (auth), Esther Pueyo (auth), Blanca Rodriguez (auth)
Formato: Electrónico Capítulo de libro
Lenguaje:inglés
Publicado: Frontiers Media SA 2018
Colección:Frontiers Research Topics
Materias:
Acceso en línea:DOAB: download the publication
DOAB: description of the publication
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!